Filing Details

Accession Number:
0001209191-18-053125
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-10-02 16:24:22
Reporting Period:
2018-10-01
Accepted Time:
2018-10-02 16:24:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1618275 Thomas Graney C/o Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-10-01 1,076 $193.24 12,430 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Mr. Graney's company-approved trading plan under Rule 10b5-1.